1. Australia Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Mesoblast Limited

Mesoblast Limited

MEOBF
Mesoblast LimitedUS flagOther OTC
1.32
USD
- -
- -
1.71BMarket Cap

Total Valuation

Mesoblast Limited carries a market capitalization of 1.71B, placing it among publicly traded companies globally. Its enterprise value stands at 2.09B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.71B
Enterprise Value2.09B

Share Statistics

Mesoblast Limited currently has 1.30B shares outstanding.

Shares Outstanding1.30B
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

PE RatioN/A
PS RatioN/A
PB Ratio3.53
P/TBV Ratio986.42
P/FCF RatioN/A
P/OCF RatioN/A

Financial Position

Mesoblast Limited maintains a current ratio of 2.43, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities.

Current Ratio2.43
Quick Ratio1.30
Debt / Equity22.40
Debt / EBITDAN/A
Interest CoverageN/A

Stock Price Statistics

Mesoblast Limited's stock has declined approximately -8.96552% over the past 52 weeks. The 50-day moving average sits at 1.74, while the 200-day moving average is 1.66.

Beta (5Y)N/A
52-Week Price Change-8.96552%
50-Day Moving Average1.74
200-Day Moving Average1.66
Average Volume (20 Days)N/A

Balance Sheet

Mesoblast Limited holds 47.39M in cash and equivalents against 127.33M in total debt, resulting in a net debt position of 71.85M. Total book value stands at 568.41M, with working capital of 116.38M providing operational flexibility.

Cash & Cash Equivalents47.39M
Total Debt127.33M
Net Debt71.85M
Equity (Book Value)568.41M
Book Value Per Share0.44
Working Capital116.38M

Cash Flow

Operating Cash FlowN/A
Capital Expenditures-898,000.00
Free Cash Flow-898,000.00
FCF Per ShareN/A

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield0.76
FCF YieldN/A

Stock Splits

Mesoblast Limited's most recent stock split took place on December 11, 2023 with a 500:527 split ratio.

Last Split Date12/11/2023
Split Ratio500:527

Scores

Mesoblast Limited posts an Altman Z-Score of -0.68, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.68